ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

British Journal of Dermatology

British Journal of Dermatology

Volume 158 Issue 5, Pages 1055 - 1062

Published Online: 18 Feb 2008

Journal compilation © 2010 British Association of Dermatologists



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 274K)  | Related Articles | Citation Tracking

THERAPEUTICS
Beneficial effect of resin salve in treatment of severe pressure ulcers: a prospective, randomized and controlled multicentre trial
A. Sipponen, J.J. Jokinen*, P. Sipponen, A. Papp, S. Sarna§ and J. Lohi
 Department of Surgery, Rheumatism Foundation Hospital, 18120 Heinola, Finland
  *Department of Cardiothoracic Surgery, Helsinki University Hospital, 00029 Helsinki, Finland
  Division of Pathology, HUSLAB, Helsinki University Hospital, Jorvi Hospital, 02740 Espoo, Finland
  BC Professional Firefighters' Burn Unit, Vancouver General Hospital, Vancouver, BC V5Z 1M9, Canada
  §Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
  Rovaniemi Health Care Centre, 96100 Rovaniemi, Finland
Correspondence to Arno Sipponen.
E-mail: arno.sipponen@repolar.com
 

Conflicts of interest
A.S., J.J.J., J.L. and P.S. have now founded a company (Repolar Ltd) for developing the resin salve as a commercial product. P.S. is a shareholder and scientific advisor of Biohit Plc, a company that markets and develops laboratory equipment and tests. There are no other conflicts of interest.

 

A.S. and J.J.J. contributed equally to this study.

Copyright Journal Compilation © 2008 British Association of Dermatologists
KEYWORDS
hydrofibre dressing • methicillin-resistant Staphylococcus aureus • pressure ulcer • randomized controlled trial • resin salve • wound healing

ABSTRACT

AbstractMaterials and methodsDiscussionAcknowledgmentsReferences

Background Resin salve of the Norway spruce (Picea abies) has been used in folk medicine to heal wounds and infections.

Objectives To study its clinical effectiveness in the treatment of pressure ulcers of the skin.

Methods A prospective, randomized, controlled multicentre trial involving 37 patients with grade II–IV pressure ulcers in 11 primary care hospitals was carried out between 2005 and 2007. The ulcers were randomly allocated to receive either resin salve or sodium carboxymethylcellulose hydrocolloid polymer treatment. The inclusion criterion was grade II–IV pressure ulcer. Exclusion criteria were a life expectancy of less than 6 months or a malignant disease. The primary outcome measure was complete healing of the ulcer within 6 months. Secondary outcome measures were partial healing of the ulcer, and successful eradication of bacterial strains cultured from the ulcers at study entry.

Results Thirteen patients of the resin group and nine patients of the control group completed the 6-month trial. All ulcers healed in 12 of the 13 patients (92%) in the resin group and in four of the nine patients (44%) in the control group (= 0·003; power 73%). Complete healing of the ulcers over time was significantly more common in the resin group than in the control group (= 0·013). Bacterial cultures from the ulcer area more often became negative within 1 month in the resin group.

Conclusions Traditional resin salve is significantly more effective in the treatment of infected and noninfected severe pressure ulcers than cellulose polymer gauzes.


Accepted for publication 9 December 2007

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1365-2133.2008.08461.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Wiley Medical Twitter